Weronika Slesak at BioEscalator

Undergraduate Biotech Entrepreneur Wins Lab Space

16 September 2021

Congratulations to undergraduate Biology student Weronika Slesak whose company Evolvere Biosciences, has been awarded laboratory space and business support with the BioEscalator for 3 months, as a prize for winning the Oxford Biotechnology Society Biohackathon 2021.

Weronika co-founded the company with fellow Oxford students Piotr Jedryszek (Biology, St Johns) and Adam Winnifrith (Biochemistry, Corpus Christi) to develop an idea for a novel treatment for antibiotic resistant bacterial infections.

Having the support of the BioEscalator – an Oxford University Biotech hub for academic scientists and entrepreneurs to collaborate -  has already allowed the young company to obtain initial proof-of-concept results; they are now seeking further funding to commence the lead optimisation process.

Antibiotic resistance is one of the biggest threats facing humanity — both in humanitarian and economic terms and Evolvere has envisioned a method to combat the evolution of antibiotic resistance by administering a safe and predictable cocktail of biologic therapeutics. This platform could not only treat patients without running the risk of inducing further resistance but also enable a relatively quick generation of cocktails targeted at new strains.

“By creating a platform for developing therapeutics that can out evolve bacteria, we want to change the way we think about treating bacterial infections and help prevent future epidemics. The current model of an infinite race between new antibiotics and the evolution of resistance induces reimbursement hurdles, which slow down the development of new antibiotics. The system fails to prevent deaths, which already total 700,000 annually. Our therapy could be game-changing”

Weronika Slesak, Co-Founder of Evolvere

Weronika Slesak